Literature DB >> 21692974

An evolutionary stress-response hypothesis for chronic widespread pain (fibromyalgia syndrome).

Pamela Lyon1, Milton Cohen, John Quintner.   

Abstract

OBJECTIVE: The study aimed to seek a unifying biological basis for the phenomena encompassed in fibromyalgia syndrome (chronic widespread pain and associated morbidities).
SETTING: While much progress has been made in the last decade in understanding chronic widespread pain, its pathogenesis remains stubbornly obscure and its treatment difficult. Two themes are gaining currency in the field: that chronic widespread pain is the result of central sensitization of nociception, and that chronic pain is somehow related to activation of a global stress response.
DESIGN: In this article we merge these two ideas within the perspective of evolutionary biology to generate a hypothesis about the critical molecular pathway involved in chronic stress response activation, namely substance P and its preferred receptor, neurokinin-1 (NK-1R), which has many empirically testable implications.
CONCLUSION: Drawing on diverse findings in neurobiology, immunology, physiology, and comparative biology, we suggest that the form of central sensitization that leads to the profound phenomenological features of chronic widespread pain is part of a whole-organism stress response, which is evolutionarily conserved, following a general pattern found in the simplest living systems. Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21692974     DOI: 10.1111/j.1526-4637.2011.01168.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  13 in total

1.  Neonatal handling (resilience) attenuates water-avoidance stress induced enhancement of chronic mechanical hyperalgesia in the rat.

Authors:  Pedro Alvarez; Jon D Levine; Paul G Green
Journal:  Neurosci Lett       Date:  2015-01-28       Impact factor: 3.046

2.  Testing the nanoparticle-allostatic cross-adaptation-sensitization model for homeopathic remedy effects.

Authors:  Iris R Bell; Mary Koithan; Audrey J Brooks
Journal:  Homeopathy       Date:  2013-01       Impact factor: 1.444

Review 3.  The role of antipsychotics in the management of fibromyalgia.

Authors:  Elena P Calandre; Fernando Rico-Villademoros
Journal:  CNS Drugs       Date:  2012-02-01       Impact factor: 5.749

4.  Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain.

Authors:  Gabriela Rocha Lauretti; Eliana Fazuoli Chubaci; Anita Leocadia Mattos
Journal:  Rheumatol Int       Date:  2013-02-20       Impact factor: 2.631

Review 5.  Neurogenic inflammation in fibromyalgia.

Authors:  Geoffrey Littlejohn; Emma Guymer
Journal:  Semin Immunopathol       Date:  2018-03-19       Impact factor: 9.623

6.  Knee pain during daily tasks, knee osteoarthritis severity, and widespread pain.

Authors:  Daniel L Riddle; Paul W Stratford
Journal:  Phys Ther       Date:  2013-11-14

Review 7.  Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome.

Authors:  Geoffrey Littlejohn
Journal:  Nat Rev Rheumatol       Date:  2015-08-04       Impact factor: 20.543

8.  Melatonin is a biomarker of circadian dysregulation and is correlated with major depression and fibromyalgia symptom severity.

Authors:  Wolnei Caumo; Maria Paz Hidalgo; Andressa Souza; Iraci L S Torres; Luciana C Antunes
Journal:  J Pain Res       Date:  2019-01-31       Impact factor: 3.133

9.  The Effects of Mindfulness-Based Mandala Coloring, Made in Nature, on Chronic Widespread Musculoskeletal Pain: Randomized Trial.

Authors:  Han Choi; Suk-Chan Hahm; Yo-Han Jeon; Jin-Woo Han; Soo-Yeon Kim; Jong-Min Woo
Journal:  Healthcare (Basel)       Date:  2021-05-28

10.  Chronic widespread bodily pain is increased among individuals with history of fracture: findings from UK Biobank.

Authors:  Karen Walker-Bone; Nicholas C Harvey; Georgia Ntani; Tannaze Tinati; Gareth T Jones; Blair H Smith; Gary J Macfarlane; Cyrus Cooper
Journal:  Arch Osteoporos       Date:  2015-12-17       Impact factor: 2.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.